The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of PBRM1, PD-L1, CD31, and CD4/CD8 ratio as a predictive signature of response to VEGFR-TKI–based therapy in patients with metastatic renal cell carcinoma (mRCC) with IMDC intermediate prognosis: Results from the APAChE-I Study.
 
Chiara Ciccarese
Consulting or Advisory Role - MSD/AstraZeneca
Speakers' Bureau - AstraZeneca; Ipsen
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Sebastiano Buti
Consulting or Advisory Role - BMS; BMS; Ipsen; Merck/Pfizer; MSD; Pfizer; Pfizer
Speakers' Bureau - BMS; Ipsen; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Michela Roberto
No Relationships to Disclose
 
Fabio Calabro
Consulting or Advisory Role - AstraZeneca; Bristol-Meyers-Squibb; Ipsen; MSD Oncology; Pfizer
Speakers' Bureau - Bristol-Myers-Squibb
 
Cristina Masini
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen; MSD
Travel, Accommodations, Expenses - Ipsen
 
Francesco Massari
No Relationships to Disclose
 
Maria Antonella Cannella
No Relationships to Disclose
 
Giulia Mazzaschi
No Relationships to Disclose
 
Serena Astore
No Relationships to Disclose
 
Stefania Di Girolamo
No Relationships to Disclose
 
Martina Panebianco
No Relationships to Disclose
 
Veronica Mollica
No Relationships to Disclose
 
Alessia Granitto
No Relationships to Disclose
 
Vincenzo Fiorentino
No Relationships to Disclose
 
Francesco Pierconti
No Relationships to Disclose
 
Maurizio Martini
No Relationships to Disclose
 
Camillo Porta
Consulting or Advisory Role - Angelini Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Eisai; EUSA Pharma
Expert Testimony - EUSA Pharma; Pfizer
Travel, Accommodations, Expenses - Roche
 
Giampaolo Tortora
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Celgene; Dompé Farmaceutici; Merck Serono; MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Roberto Iacovelli
Honoraria - Astellas Pharma; IPSEN; MSD; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Eisai; Janssen; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; MSD; Pfizer; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer